ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$22.58
Tradestie Score
56
Market Cap
$2.22B
Revenue Growth
0.4%
Analyst Upside
-2.6%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$132.53
|
$5.76B | 231.7 | 54 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.40
|
$4.60B | 43.6 | 47 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$61.65
|
$3.26B | - | 55 | Compare |
|
VCYT
Veracyte, Inc.
|
$59.53
|
$2.85B | 54.5 | 54 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$27.29
|
$2.44B | - | 51 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$72.71
|
$2.24B | - | 58 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$95.86
|
$1.77B | - | 55 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$47.20
|
$1.54B | - | 57 | Compare |
|
NEOG
Neogen Corp
|
$9.93
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.21
|
$1.23B | - | 55 | Compare |
More ADPT Analysis
Data updated: Jul 21, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry